531 established models ※As of May 2024
No. | Sex | Age | Sample collection method | Cancer type (Major Categories) |
Cancer type (Subcategory) |
Histology | Collection site Primary/Metastasis |
Stage | Prior-chemotherapy | Gene alteration |
---|---|---|---|---|---|---|---|---|---|---|
Female | 60s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | Pan-Wild | |
Male | 70s | Biopsy | Rare cancers and sarcomas | Lung Cancer | Small cell carcinoma | Metastasis | Stage4 | Naïve | Pan-Wild | |
Female | 40s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage3 | Treated | EGFR ex21 L858R | |
Male | 60s | Biopsy | Gastric cancer | Gastric cancer | Adenocarcinoma(por) | Primary | Stage4 | Treated | ||
Male | 30s | Biopsy | Rare cancers and sarcomas | Dermatofibrosarcoma Protuberans | Metastasis | Recurrence | Treated | |||
Male | 60s | Biopsy | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Metastasis | Stage4 | Naïve | Pan-Wild | |
Male | 60s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Surgery | Rare cancers and sarcomas | Malignant peripheral nerve sheath tumor | Metastasis | Recurrence | Treated | |||
Male | 70s | Surgery | Thyroid cancer | Thyroid cancer | Papillary carcinoma | Metastasis | Stage4 | Naïve | ||
Male | 60s | Biopsy | Gastric cancer | Gastric cancer | Adenocarcinoma(por) | Metastasis | Stage4 | Treated | ||
Male | 60s | Biopsy | Rare cancers and sarcomas | Malignant pleural mesothelioma | Biphasic type | Primary | Stage3 | Naïve | ||
Male | 40s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ALK fusion | |
Male | 70s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | EGFR ex19 del, T790M | |
Female | 10s | Biopsy | Rare cancers and sarcomas | Rhabdomyosarcoma | Follicular type | Metastasis | Recurrence | Treated | ||
Female | 70s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ALK fusion | |
Male | 30s | Biopsy | Rare cancers and sarcomas | Ewing's sarcoma | Metastasis | Recurrence | Treated | |||
Male | 60s | Surgery | Colorectal cancer | Rectal and cecum cancer | Ductal adenocarcinoma | Primary | Stage4 | Naïve | EGFR 3+ | |
Female | 40s | Surgery | Breast cancer | Breast cancer | Invasive ductal carcinoma | Primary | Stage1 | Treated | TNBC | |
Male | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 50s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | Pan-Wild | |
Female | 50s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Male | 10s | Biopsy | Rare cancers and sarcomas | Ewing's sarcoma | Metastasis | Recurrence | Treated | |||
Male | 70s | Biopsy | Colorectal cancer | Transverse colon cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | EGFR 2+ | |
Male | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 50s | Biopsy | Lung Cancer | Lung Cancer | Non-small cell carcinoma | Primary | Stage4 | Naïve | Pan-Wild | |
Male | 70s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | KRAS G12V | |
Female | 40s | Surgery | Breast cancer | Breast cancer | Metaplastic carcinoma | Primary | Stage3 | Treated | LuminalA | |
Male | 10s | Biopsy | Rare cancers and sarcomas | Rhabdomyosarcoma | Follicular type | Metastasis | Recurrence | Naïve | ||
Male | 40s | Biopsy | Rare cancers and sarcomas | Adenoid cystic carcinoma | Metastasis | Recurrence | Naïve | |||
Male | 70s | Surgery | Colorectal cancer | Rectal and sigmoid colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 50s | Surgery | Breast cancer | Breast cancer | Metaplastic carcinoma | Primary | Stage2 | Naïve | TNBC | |
Male | 20s | Biopsy | Lymphoma | Burkitt's lymphoma | Metastasis | Stage1 | Naïve | |||
Female | 10s | Biopsy | Rare cancers and sarcomas | NUT midline carcinoma | Metastasis | Not Assessed | Treated | |||
Male | 60s | Biopsy | Rare cancers and sarcomas | Malignant pleural mesothelioma | Biphasic type | Metastasis | Stage3 | Treated | ||
Female | 50s | Biopsy | Breast cancer | Breast cancer | Invasive carcinoma | Metastasis | Recurrence | Treated | TNBC | |
Female | 70s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ALK fusion | |
Female | 40s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 40s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Male | 50s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | Pan-Wild | |
Female | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 60s | Surgery | Rare cancers and sarcomas | Thymic carcinoma | Basal cell carcinoma | Primary | Stage4 | Naïve | ||
Female | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage3 | Treated | ||
Female | 70s | Biopsy | Pancreatic cancer | Pancreatic cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Male | 60s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 70s | Surgery | Oropharyngeal cancer | Oropharyngeal cancer | Squamous cell carcinoma | Metastasis | Recurrence | Treated | ||
Male | 70s | Surgery | Rare cancers and sarcomas | Intrahepatic bile duct cancer | Ductal adenocarcinoma + Mixed adenoneuroendocrine carcinoma | Metastasis | Recurrence | Naïve | ||
Female | 60s | Biopsy | Bile duct cancer | Gallbladder cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | ||
Male | 50s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ROS1 fusion | |
Female | 70s | Surgery | Breast cancer | Breast cancer | Non-invasive lobular carcinoma | Primary | Stage3 | Treated | HER2 | |
Female | 50s | Biopsy | Rare cancers and sarcomas | Uterine carcinosarcoma | Metastasis | Stage4 | Treated | |||
Male | 70s | Biopsy | Rare cancers and sarcomas | Lung Cancer | Small cell carcinoma | Metastasis | Stage3 | Naïve | ||
Male | 70s | Biopsy | Pancreatic cancer | Pancreatic cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Rectosigmoid cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 60s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 70s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 40s | Surgery | Brain cancer | Glioblastoma | IDH wild type | Primary | Not Assessed | Naïve | ||
Female | 80s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | EGFR ex21 L858R | |
Female | 80s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | EGFR ex21 L858R | |
Female | 70s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | ||
Male | 20s | Surgery | Rare cancers and sarcomas | Synovial sarcoma | Biphasic type | Metastasis | Recurrence | Treated | ||
Female | 10s | Surgery | Rare cancers and sarcomas | Rhabdomyosarcoma | Follicular type | Metastasis | Stage4 | Naïve | ||
Male | 70s | Biopsy | Bile duct cancer | Gallbladder cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Male | 50s | Biopsy | Rare cancers and sarcomas | Malignant pleural mesothelioma | Epithelial type | Metastasis | Recurrence | Treated | ||
Male | 70s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Female | 40s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 60s | Surgery | Rare cancers and sarcomas | Uterine carcinosarcoma | Metastasis | Recurrence | Treated | |||
Male | 70s | Surgery | Rare cancers and sarcomas | Lung Cancer | Pleomorphic carcinoma | Primary | Recurrence | Naïve | Pan-Wild | |
Male | 60s | Biopsy | Pancreatic cancer | Pancreatic cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 50s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 40s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Biopsy | Pancreatic cancer | Pancreatic cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 30s | Biopsy | Lung Cancer | Lung Cancer | Non-small cell carcinoma | Primary | Stage4 | Treated | ALK fusion | |
Male | 70s | Surgery | Esophageal cancer | Esophageal cancer | Squamous cell carcinoma | Metastasis | Recurrence | Treated | ||
Female | 70s | Biopsy | Pancreatic cancer | Pancreatic cancer | Adenosquamous carcinoma | Primary | Stage4 | Naïve | ||
Female | 60s | Biopsy | Bile duct cancer | Gallbladder cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Ascending colon cancer | Mucinous carcinoma | Primary | Stage2 | Naïve | ||
Female | 50s | Surgery | Rare cancers and sarcomas | Leiomyosarcoma | Metastasis | Recurrence | Treated | |||
Female | 70s | Biopsy | Pancreatic cancer | Pancreatic cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Male | 70s | Surgery | Rare cancers and sarcomas | Lung Cancer | Large cell neuroendocrine carcinoma | Primary | Stage3 | Naïve | Pan-Wild | |
Female | 70s | Surgery | Breast cancer | Breast cancer | Invasive ductal carcinoma | Primary | Stage2 | Naïve | TNBC | |
Male | 70s | Biopsy | Gastric cancer | Gastric cancer | Adenocarcinoma(well) | Primary | Stage4 | Treated | ||
Female | 50s | Surgery | Rare cancers and sarcomas | CIC gene rearranged sarcoma | Metastasis | Recurrence | Naïve | |||
Female | 60s | Biopsy | Rare cancers and sarcomas | Gallbladder cancer | NEC | Metastasis | Stage4 | Naïve | ||
Male | 60s | Surgery | Esophageal cancer | Esophageal cancer | Squamous cell carcinoma | Primary | Stage4 | Treated | ||
Male | 60s | Biopsy | Esophageal cancer | Esophageal cancer | Squamous cell carcinoma | Primary | Stage3 | Naïve | ||
Female | 70s | Biopsy | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Metastasis | Stage4 | Treated | ||
Female | 50s | Surgery | Rare cancers and sarcomas | CIC gene rearranged sarcoma | Primary | Not Assessed | Treated | |||
Male | 70s | Surgery | Rare cancers and sarcomas | Adenoid cystic carcinoma | Metastasis | Not Assessed | Naïve | |||
Female | 70s | Surgery | Breast cancer | Breast cancer | Invasive ductal carcinoma | Metastasis | Recurrence | Treated | TNBC | |
Male | 50s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage3 | Naïve | Pan-Wild | |
Female | 30s | Surgery | Rare cancers and sarcomas | Intimal sarcoma | Metastasis | Recurrence | Naïve | |||
Female | 10s | Biopsy | Rare cancers and sarcomas | Rhabdomyosarcoma | Follicular type | Metastasis | Recurrence | Treated | ||
Female | 50s | Surgery | Breast cancer | Breast cancer | Invasive ductal carcinoma | Primary | Stage2 | Naïve | HER2 | |
Male | 80s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage3 | Naïve | ||
Female | 80s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Female | 70s | Surgery | Rare cancers and sarcomas | Osteosarcoma | Telangiectatic | Metastasis | Recurrence | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 30s | Biopsy | Rare cancers and sarcomas | NUT midline carcinoma | Metastasis | Not Assessed | Naïve | |||
Male | 40s | Surgery | Rare cancers and sarcomas | Leiomyosarcoma | Metastasis | Recurrence | Treated | |||
Male | 70s | Surgery | Rare cancers and sarcomas | Inflammatory myofibroblast tumor | Primary | Not Assessed | Naïve | |||
Male | 60s | Surgery | Rare cancers and sarcomas | Lung Cancer | Combined small cell carcinoma | Primary | Stage2 | Naïve | ||
Male | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Female | 80s | Surgery | Brain cancer | Glioblastoma | IDH wild type | Primary | Not Assessed | Naïve | ||
Male | 60s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage1 | Naïve | ||
Male | 50s | Biopsy | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | HER2, KRAS G12V | |
Male | 50s | Surgery | Brain cancer | Glioblastoma | IDH wild type | Primary | Not Assessed | Naïve | ||
Female | 50s | Surgery | Breast cancer | Breast cancer | Metaplastic carcinoma | Primary | Stage3 | Naïve | TNBC | |
Male | 60s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage4 | Naïve | Pan-Wild | |
Female | 40s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 10s | Biopsy | Rare cancers and sarcomas | Osteosarcoma | Metastasis | Recurrence | Treated | |||
Male | 60s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage1 | Naïve | ||
Female | 50s | Biopsy | Bile duct cancer | Gallbladder cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ||
Male | 70s | Surgery | Esophageal cancer | Esophageal cancer | Squamous cell carcinoma | Primary | Stage3 | Treated | ||
Male | 60s | Surgery | Gastric cancer | Gastric cancer | Adenocarcinoma(por to mod) | Primary | Stage3 | Treated | ||
Male | 60s | Surgery | Rare cancers and sarcomas | Lung Cancer | Combined small cell carcinoma | Metastasis | Stage4 | Naïve | ||
Female | 50s | Surgery | Brain cancer | Anaplastic oligodendroglioma | IDH mutant | Primary | Recurrence | Treated | ||
Female | 60s | Biopsy | Rare cancers and sarcomas | Gallbladder cancer | NEC | Metastasis | Recurrence | Treated | ||
Male | 50s | Biopsy | Pancreatic cancer | Pancreatic cancer | Pancreatic acinar cell carcinoma | Metastasis | Recurrence | Treated | ||
Male | 60s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Male | 50s | Surgery | Gastric cancer | Gastric cancer | Adenocarcinoma(por) | Metastasis | Recurrence | Treated | ||
Male | 40s | Biopsy | Colorectal cancer | Appendiceal carcinoma | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 50s | Biopsy | Colorectal cancer | Rectal cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | BRAF V600E | |
Female | 10s | Biopsy | Rare cancers and sarcomas | Osteosarcoma | Metastasis | Recurrence | Treated | |||
Female | 50s | Surgery | Colorectal cancer | Cecal carcinoma | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Female | 40s | Surgery | Cervical cancer | Cervical cancer | Squamous cell carcinoma | Primary | Stage1 | Naïve | ||
Male | 80s | Surgery | Brain cancer | Glioblastoma | IDH wild type | Primary | Not Assessed | Naïve | ||
Male | 40s | Surgery | Brain cancer | Glioblastoma | IDH wild type | Primary | Not Assessed | Naïve | ||
Male | 20s | Surgery | Rare cancers and sarcomas | Synovial sarcoma | Biphasic type | Metastasis | Recurrence | Treated | ||
Male | 50s | Biopsy | Bile duct cancer | Intrahepatic bile duct cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Female | 50s | Biopsy | Breast cancer | Breast cancer | Metaplastic carcinoma | Metastasis | Recurrence | Naïve | TNBC | |
Male | 50s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | Pan-Wild | |
Male | 60s | Surgery | Rare cancers and sarcomas | Lung Cancer | Pleomorphic carcinoma | Primary | Stage2 | Naïve | ||
Male | 40s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Biopsy | Rare cancers and sarcomas | Lung Cancer | Small cell carcinoma | Metastasis | Recurrence | Treated | ||
Male | 70s | Surgery | Colorectal cancer | Colorectal cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Female | 60s | Surgery | Melanoma | Melanoma | Metastasis | Recurrence | Treated | |||
Female | 80s | Biopsy | Pancreatic cancer | Pancreatic cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Female | 60s | Surgery | Pancreatic cancer | Pancreatic cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 70s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 60s | Biopsy | Ovarian cancer | Ovarian cancer | Highly heterotypic serous adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 30s | Biopsy | Rare cancers and sarcomas | Lung Cancer | Combined small cell carcinoma | Metastasis | Recurrence | Treated | Pan-Wild | |
Female | 80s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 70s | Surgery | Colorectal cancer | Transverse colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 40s | Surgery | Brain cancer | Glioblastoma | IDH wild type | Primary | Recurrence | Treated | ||
Male | 50s | Surgery | Esophageal cancer | Esophageal cancer | Squamous cell carcinoma | Primary | Stage4 | Treated | ||
Male | 60s | Biopsy | Bile duct cancer | Intrahepatic bile duct cancer | Ductal adenocarcinoma | Metastasis | Stage3 | Treated | ||
Female | 30s | Surgery | Breast cancer | Breast cancer | Malignant lobular tumor | Primary | Recurrence | Treated | ||
Female | 40s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Metastasis | Recurrence | Treated | EGFR ex19 del | |
Female | 40s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 40s | Surgery | Rare cancers and sarcomas | Liposarcoma | Dedifferentiated | Metastasis | Recurrence | Naïve | ||
Female | 30s | Surgery | Cervical cancer | Cervical cancer | Gastric-type mucinous adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 50s | Surgery | Rare cancers and sarcomas | Lung Cancer | Large cell carcinoma | Primary | Stage2 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 20s | Biopsy | Rare cancers and sarcomas | Synovial sarcoma | Metastasis | Recurrence | Treated | |||
Female | 70s | Surgery | Pancreatic cancer | Pancreatic cancer | Pancreatic acinar cell carcinoma | Primary | Stage2 | Naïve | ||
Female | 30s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Surgery | Brain cancer | Glioblastoma | IDH wild type | Primary | Not Assessed | Naïve | ||
Male | 10s | Biopsy | Rare cancers and sarcomas | Rhabdomyosarcoma | Follicular type | Primary | Not Assessed | Naïve | ||
Female | 50s | Biopsy | Ovarian cancer | Ovarian cancer | Highly heterotypic serous adenocarcinoma | Metastasis | Stage3 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Cecal carcinoma | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Female | 30s | Surgery | Breast cancer | Breast cancer | Invasive ductal carcinoma | Primary | Stage2 | Treated | LuminalA | |
Female | 80s | Surgery | Brain cancer | Glioblastoma | IDH wild type | Primary | Not Assessed | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 60s | Biopsy | Bile duct cancer | Intrahepatic bile duct cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ||
Male | 60s | Surgery | Rare cancers and sarcomas | Lung Cancer | Combined small cell carcinoma | Primary | Recurrence | Treated | ||
Female | 60s | Biopsy | Ovarian cancer | Ovarian cancer | Highly heterotypic serous adenocarcinoma | Metastasis | Recurrence | Treated | ||
Female | 50s | Surgery | Colorectal cancer | Cecal carcinoma | Adenocarcinoma | Primary | Stage4 | Treated | KRAS G12V | |
Male | 60s | Surgery | Pancreatic cancer | Pancreatic cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Male | 80s | Surgery | Gastric cancer | Gastric cancer | Adenocarcinoma + mucinous carcinoma(mod to por) | Primary | Stage3 | Naïve | ||
Male | 60s | Biopsy | Bile duct cancer | Intrahepatic bile duct cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | KRAS G12D | |
Female | 50s | Surgery | Breast cancer | Breast cancer | Invasive ductal carcinoma | Metastasis | Recurrence | Treated | HER2 | |
Male | 70s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Female | 50s | Biopsy | Rare cancers and sarcomas | CIC gene rearranged sarcoma | Metastasis | Recurrence | Treated | |||
Female | 70s | Surgery | Endometrial cancer | Endometrial cancer | Clear cell adenocarcinoma | Primary | Stage4 | Naïve | ||
Female | 50s | Surgery | Rare cancers and sarcomas | Lung Cancer | Pleomorphic carcinoma | Primary | Stage4 | Naïve | Pan-Wild | |
Male | 10s | Biopsy | Rare cancers and sarcomas | Osteosarcoma | Primary | Stage2 | Naïve | |||
Male | 40s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | Pan-Wild | |
Female | 40s | Surgery | Breast cancer | Breast cancer | Invasive ductal carcinoma | Primary | Stage3 | Naïve | LuminalA | |
Male | 60s | Surgery | Esophageal cancer | Esophageal cancer | Squamous cell carcinoma | Primary | Stage3 | Treated | ||
Female | 60s | Biopsy | Ovarian cancer | Ovarian cancer | Highly heterotypic serous adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 20s | Biopsy | Rare cancers and sarcomas | Epithelioid sarcoma | Metastasis | Recurrence | Treated | |||
Female | 50s | Surgery | Breast cancer | Breast cancer | Invasive ductal carcinoma | Metastasis | Recurrence | Treated | LuminalA | |
Male | 70s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | ||
Female | 50s | Biopsy | Rare cancers and sarcomas | Thymic carcinoma | Squamous cell carcinoma | Metastasis | Recurrence | Treated | ||
Male | 40s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Female | 50s | Biopsy | Breast cancer | Breast cancer | Invasive ductal carcinoma | Metastasis | Recurrence | Treated | LuminalA | |
Male | 20s | Biopsy | Rare cancers and sarcomas | Germ cell tumor | Mixed type | Metastasis | Recurrence | Treated | ||
Female | 60s | Surgery | Endometrial cancer | Endometrial cancer | Serous adenocarcinoma | Primary | Stage4 | Naïve | ||
Female | 30s | Biopsy | Breast cancer | Breast cancer | Invasive ductal carcinoma | Primary | Stage4 | Treated | HER2 | |
Female | 50s | Biopsy | Breast cancer | Breast cancer | Invasive ductal carcinoma | Metastasis | Recurrence | Treated | LuminalA | |
Male | 60s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | KRAS G12S | |
Male | 50s | Biopsy | Bile duct cancer | Intrahepatic bile duct cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | KRAS G12V | |
Female | 30s | Biopsy | Breast cancer | Breast cancer | Invasive ductal carcinoma | Metastasis | Recurrence | Treated | TNBC | |
Female | 50s | Surgery | Rare cancers and sarcomas | Dermatofibrosarcoma Protuberans | Metastasis | Recurrence | Naïve | |||
Female | 70s | Surgery | Esophageal cancer | Esophageal cancer | Squamous cell carcinoma | Primary | Stage4 | Treated | ||
Female | 50s | Surgery | Brain cancer | Anaplastic oligodendroglioma | IDH mutant | Primary | Recurrence | Treated | ||
Female | 50s | Surgery | Rare cancers and sarcomas | Dermatofibrosarcoma Protuberans | Metastasis | Recurrence | Treated | |||
Male | 50s | Surgery | Pancreatic cancer | Pancreatic cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Female | 70s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 30s | Surgery | Cervical cancer | Cervical cancer | Squamous cell carcinoma | Primary | Stage4 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Female | 50s | Surgery | Colorectal cancer | Transverse colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Female | 30s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Metastasis | Stage4 | Treated | Pan-Wild | |
Female | 80s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ROS1 fusion | |
Male | 50s | Surgery | Brain cancer | Glioblastoma | IDH wild type | Primary | Not Assessed | Naïve | ||
Male | 60s | Surgery | Esophageal cancer | Esophageal cancer | Squamous cell carcinoma | Primary | Stage4 | Treated | ||
Male | 40s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ALK fusion | |
Male | 60s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | Pan-Wild | |
Female | 30s | Surgery | Rare cancers and sarcomas | Vulvar cancer | Squamous cell carcinoma | Primary | Stage3 | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Rectal and sigmoid colon cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 60s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage1 | Naïve | ||
Female | 10s | Surgery | Rare cancers and sarcomas | Osteosarcoma | Metastasis | Recurrence | Treated | |||
Female | 60s | Surgery | Rare cancers and sarcomas | Cancer of unknown primary | Adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Female | 40s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 70s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Recurrence | Naïve | ||
Female | 40s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 60s | Biopsy | Bile duct cancer | Intrahepatic bile duct cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | ||
Male | 50s | Biopsy | Bile duct cancer | Intrahepatic bile duct cancer | Adenocarcinoma | Metastasis | Stage3 | Treated | ||
Female | 30s | Surgery | Rare cancers and sarcomas | Cancer of unknown primary | Neuroendocrine carcinoma | Metastasis | Not Assessed | Naïve | ||
Female | 60s | Surgery | Rare cancers and sarcomas | Adenoid cystic carcinoma | Primary | Stage1 | Naïve | |||
Female | 70s | Biopsy | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage4 | Naïve | ||
Female | 50s | Biopsy | Rare cancers and sarcomas | Small intestine cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Female | 10s | Biopsy | Rare cancers and sarcomas | Osteosarcoma | Metastasis | Recurrence | Treated | |||
Male | 70s | Surgery | Bile duct cancer | Intrahepatic bile duct cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Male | 70s | Biopsy | Rare cancers and sarcomas | Pancreatic cancer | Hepatoid carcinoma | Primary | Not Assessed | Naïve | ||
Female | 60s | Surgery | Endometrial cancer | Endometrial cancer | Endometrial adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Male | 70s | Surgery | Lung Cancer | Lung Cancer | Mucinous adenocarcinoma | Primary | Stage1 | Naïve | KRAS G12C | |
Female | 70s | Biopsy | Rare cancers and sarcomas | Lung Cancer | Small cell carcinoma | Metastasis | Stage4 | Treated | EGFR L861Q | |
Female | 50s | Surgery | Brain cancer | Glioblastoma | IDH wild type | Primary | Recurrence | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | KRAS G12D | |
Female | 50s | Surgery | Rare cancers and sarcomas | Uterine adenosarcoma | Primary | Stage4 | Naïve | |||
Female | 70s | Surgery | Endometrial cancer | Endometrial cancer | Endometrial adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 60s | Surgery | Colorectal cancer | Rectosigmoid cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 70s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage2 | Naïve | ||
Male | 60s | Surgery | Gastric cancer | Gastric cancer | Adenocarcinoma(mod to diff) | Primary | Stage3 | Treated | ||
Male | 40s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 50s | Surgery | Colorectal cancer | Rectosigmoid cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 50s | Surgery | Pancreatic cancer | Pancreatic cancer | Unclassified carcinoma | Metastasis | Recurrence | Naïve | ||
Male | 70s | Surgery | Melanoma | Melanoma | Primary | Stage2 | Naïve | |||
Male | 80s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Female | 60s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | ||
Female | 50s | Surgery | Bile duct cancer | Intrahepatic bile duct cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ||
Female | 60s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | Pan-Wild | |
Female | 40s | Surgery | Breast cancer | Breast cancer | Invasive ductal carcinoma | Metastasis | Recurrence | Treated | TNBC | |
Male | 80s | Surgery | Gastric cancer | Esophagogastric junction carcinoma | Adenocarcinoma(por) | Primary | Stage4 | Naïve | ||
Female | 60s | Biopsy | Breast cancer | Breast cancer | Invasive ductal carcinoma | Metastasis | Recurrence | Treated | LuminalA | |
Male | 70s | Biopsy | Rare cancers and sarcomas | Lung Cancer | Small cell carcinoma | Metastasis | Stage4 | Naïve | ||
Male | 30s | Surgery | Rare cancers and sarcomas | Chondrosarcoma | Mesenchymal | Metastasis | Recurrence | Treated | ||
Female | 40s | Surgery | Brain cancer | Glioblastoma | IDH wild type | Primary | Recurrence | Treated | ||
Male | 40s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 50s | Surgery | Endometrial cancer | Endometrial cancer | Endometrial adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 40s | Surgery | Breast cancer | Breast cancer | Invasive ductal carcinoma | Primary | Stage1 | Naïve | TNBC | |
Male | 70s | Biopsy | Rare cancers and sarcomas | Pleomorphic sarcoma | Metastasis | Recurrence | Treated | |||
Male | 70s | Biopsy | Rare cancers and sarcomas | Lung Cancer | Small cell carcinoma | Metastasis | Recurrence | Treated | ||
Female | 40s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | EGFR ex21 L858R | |
Female | 60s | Surgery | Ovarian cancer | Ovarian cancer | Clear cell adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 70s | Surgery | Rare cancers and sarcomas | Lung Cancer | Pleomorphic carcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Surgery | Melanoma | Melanoma | Primary | Stage3 | Naïve | |||
Male | 80s | Surgery | Rare cancers and sarcomas | Myxofibrosarcoma | High grade | Primary | Not Assessed | Naïve | ||
Female | 70s | Biopsy | Breast cancer | Breast cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | LuminalA | |
Female | 50s | Biopsy | Ovarian cancer | Ovarian cancer | Highly heterotypic serous adenocarcinoma | Metastasis | Recurrence | Treated | ||
Female | 40s | Biopsy | Ovarian cancer | Ovarian cancer | Low atypical serous adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 70s | Biopsy | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Metastasis | Recurrence | Treated | Pan-Wild | |
Female | 60s | Biopsy | Lung Cancer | Lung Cancer | Non-small cell carcinoma | Metastasis | Stage4 | Treated | Pan-Wild | |
Female | 80s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | EGFR ex19 del, EGFR ex21 L858R | |
Male | 70s | Surgery | Gastric cancer | Gastric cancer | Adenocarcinoma(well) | Primary | Stage1 | Naïve | ||
Female | 70s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Female | 60s | Surgery | Endometrial cancer | Endometrial cancer | Mixed adenocarcinoma | Primary | Stage1 | Naïve | ||
Female | 10s | Biopsy | Rare cancers and sarcomas | Osteosarcoma | Primary | Stage2 | Naïve | |||
Male | 70s | Surgery | Gastric cancer | Esophagogastric junction carcinoma | Adenocarcinoma + signet-ring cell carcinoma(por) | Primary | Stage4 | Treated | ||
Male | 70s | Biopsy | Bile duct cancer | Gallbladder cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 10s | Biopsy | Rare cancers and sarcomas | Osteosarcoma | Metastasis | Recurrence | Treated | |||
Male | 50s | Surgery | Gastric cancer | Esophagogastric junction carcinoma | Adenocarcinoma(mod to well) | Primary | Stage3 | Naïve | ||
Female | 50s | Biopsy | Endometrial cancer | Endometrial cancer | Endometrial adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Female | 50s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ||
Female | 50s | Biopsy | Rare cancers and sarcomas | Malignant pleural mesothelioma | Epithelial type | Metastasis | Stage4 | Treated | ||
Male | 80s | Biopsy | Rare cancers and sarcomas | Gastric cancer | NET, NEC | Metastasis | Recurrence | Naïve | ||
Female | 70s | Biopsy | Rare cancers and sarcomas | Adenoid cystic carcinoma | Metastasis | Recurrence | Treated | |||
Male | 40s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage4 | Treated | Pan-Wild | |
Female | 60s | Surgery | Rare cancers and sarcomas | Perivascular epithelioid cell tumor | Primary | Not Assessed | Naïve | |||
Female | 50s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | RET fusion | |
Female | 10s | Biopsy | Rare cancers and sarcomas | Rhabdomyosarcoma | Fetal type | Metastasis | Stage4 | Treated | ||
Female | 40s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 70s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Female | 70s | Surgery | Endometrial cancer | Endometrial cancer | Endometrial adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 30s | Surgery | Ovarian cancer | Ovarian cancer | Yolk sac tumor | Primary | Recurrence | Naïve | ||
Female | 40s | Surgery | Ovarian cancer | Ovarian cancer | Highly heterotypic serous adenocarcinoma | Primary | Stage1 | Naïve | ||
Male | 60s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage3 | Naïve | ||
Male | <10 | Biopsy | Rare cancers and sarcomas | Rhabdomyosarcoma | Follicular type | Primary | Recurrence | Treated | ||
Female | 40s | Surgery | Rare cancers and sarcomas | Uterine carcinosarcoma | Primary | Stage3 | Naïve | |||
Male | 50s | Surgery | Bile duct cancer | Intrahepatic bile duct cancer | Adenocarcinoma | Metastasis | Stage2 | Naïve | ||
Male | 60s | Surgery | Esophageal cancer | Esophageal cancer | Squamous cell carcinoma | Primary | Stage3 | Treated | ||
Female | 30s | Surgery | Rare cancers and sarcomas | Germ cell tumor | Yolk sac tumor | Primary | Not Assessed | Naïve | ||
Male | 50s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage2 | Naïve | Pan-Wild | |
Female | 50s | Surgery | Ovarian cancer | Ovarian cancer | Clear cell carcinoma | Metastasis | Stage3 | Treated | ||
Male | 20s | Biopsy | Rare cancers and sarcomas | NUT midline carcinoma | Metastasis | Not Assessed | Naïve | |||
Male | 70s | Biopsy | Rare cancers and sarcomas | Lung Cancer | Small cell carcinoma | Metastasis | Stage1 | Treated | Pan-Wild | |
Female | 40s | Biopsy | Breast cancer | Breast cancer | Invasive ductal carcinoma | Metastasis | Recurrence | Treated | LuminalB | |
Female | 50s | Surgery | Ovarian cancer | Ovarian cancer | Clear cell carcinoma | Metastasis | Stage3 | Treated | ||
Female | <10 | Biopsy | Rare cancers and sarcomas | Retinoblastoma | Metastasis | Recurrence | Treated | |||
Female | 70s | Surgery | Cervical cancer | Cervical cancer | Gastric type adenocarcinoma | Primary | Stage4 | Treated | ||
Female | 40s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | BRAF V600E | |
Female | 30s | Surgery | Rare cancers and sarcomas | Cervical cancer | Small cell neuroendocrine carcinoma | Primary | Stage1 | Naïve | ||
Female | 30s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ALK fusion | |
Female | 40s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | EGFR ex19 del, T790M | |
Male | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Female | 60s | Surgery | Rare cancers and sarcomas | Rhabdomyosarcoma | Pleomorphic type | Metastasis | Recurrence | Treated | ||
Female | 70s | Biopsy | Lung Cancer | Lung Cancer | Non-small cell carcinoma | Metastasis | Stage3 | Naïve | ||
Female | 10s | Biopsy | Rare cancers and sarcomas | Osteosarcoma | Metastasis | Not Assessed | Treated | |||
Female | 70s | Biopsy | Ovarian cancer | Ovarian cancer | Serous adenocarcinoma | Metastasis | Recurrence | Treated | ||
Female | 10s | Surgery | Rare cancers and sarcomas | Osteosarcoma | Primary | Recurrence | Treated | |||
Male | 70s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage3 | Naïve | KRAS G12A | |
Male | 60s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Recurrence | Treated | ||
Male | 40s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | ||
Female | 30s | Surgery | Rare cancers and sarcomas | Osteosarcoma | Metastasis | Recurrence | Treated | |||
Female | 10s | Surgery | Rare cancers and sarcomas | Malignant rhabdoid tumor | Primary | Not Assessed | Naïve | |||
Female | 70s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage1 | Naïve | ||
Male | 70s | Surgery | Thyroid cancer | Thyroid cancer | Squamous cell carcinoma | Metastasis | Recurrence | Treated | ||
Male | 40s | Surgery | Rare cancers and sarcomas | Lung Cancer | Combined small cell carcinoma/neuroendocrine carcinoma | Primary | Stage3 | Naïve | Pan-Wild | |
Female | 50s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | EGFR ex19 del | |
Female | 70s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | Pan-Wild | |
Female | 50s | Surgery | Ovarian cancer | Ovarian cancer | Clear cell carcinoma | Primary | Stage3 | Naïve | ||
Female | 40s | Surgery | Endometrial cancer | Endometrial cancer | Endometrial adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 10s | Biopsy | Rare cancers and sarcomas | Neuroblastoma | Metastasis | Recurrence | Treated | |||
Male | 40s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | KRAS G12V | |
Male | 60s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage1 | Naïve | Pan-Wild | |
Male | 70s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage2 | Naïve | Pan-Wild | |
Female | 70s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Male | 10s | Biopsy | Rare cancers and sarcomas | Rhabdomyosarcoma | Follicular type | Metastasis | Recurrence | Treated | ||
Male | 70s | Surgery | Rare cancers and sarcomas | Lung Cancer | Large cell carcinoma | Primary | Stage1 | Naïve | Pan-Wild | |
Female | 20s | Surgery | Rare cancers and sarcomas | Rhabdomyosarcoma | Follicular type | Metastasis | Recurrence | Treated | ||
Female | 60s | Biopsy | Pancreatic cancer | Pancreatic cancer | Ductal adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Male | 60s | Biopsy | Hepatocellular carcinoma | Hepatocellular carcinoma | Highly differentiated | Metastasis | Stage4 | Naïve | ||
Female | 60s | Surgery | Gastric cancer | Gastric cancer | Adenocarcinoma(por) | Primary | Stage4 | Treated | ||
Female | 50s | Surgery | Rare cancers and sarcomas | Uterine carcinosarcoma | Primary | Stage3 | Naïve | |||
Male | 60s | Biopsy | Bile duct cancer | Intrahepatic bile duct cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Female | 40s | Surgery | Bladder cancer | Bladder cancer | Urothelial carcinoma | Metastasis | Recurrence | Treated | ||
Female | 40s | Surgery | Renal cell cancer | Renal cell cancer | Pallidoblastic renal cell carcinoma | Metastasis | Recurrence | Treated | ||
Male | 70s | Surgery | Colorectal cancer | Rectosigmoid cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Transverse colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Female | 60s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | EGFR ex19 del | |
Male | 60s | Surgery | Rare cancers and sarcomas | Lung Cancer | Small cell carcinoma | Primary | Stage1 | Naïve | ||
Female | 70s | Surgery | Ovarian cancer | Ovarian cancer | Clear cell adenocarcinoma | Primary | Stage4 | Treated | ||
Female | 50s | Surgery | Rare cancers and sarcomas | Uterine carcinosarcoma | Primary | Stage4 | Naïve | |||
Female | 60s | Surgery | Ovarian cancer | Ovarian cancer | Highly heterotypic serous adenocarcinoma | Primary | Stage3 | Treated | ||
Male | 40s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | KRAS G12V | |
Male | 60s | Surgery | Colorectal cancer | Rectal and sigmoid colon cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Male | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 70s | Surgery | Colorectal cancer | Rectal and cecum cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 50s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 70s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Male | 80s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Transverse colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 40s | Surgery | Colorectal cancer | Transverse colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 70s | Surgery | Colorectal cancer | Rectosigmoid cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 60s | Surgery | Colorectal cancer | Rectosigmoid cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 50s | Surgery | Colorectal cancer | Rectosigmoid cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Transverse colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Cecal carcinoma | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage4 | Naïve | KRAS G13D | |
Male | 40s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Metastasis | Recurrence | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Male | 30s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 70s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Female | 70s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Female | 50s | Surgery | Rare cancers and sarcomas | Ovarian carcinosarcoma | Ovarian carcinosarcoma | Primary | Stage1 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 80s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Descending colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 60s | Surgery | Esophageal cancer | Esophageal cancer | Squamous cell carcinoma | Primary | Stage3 | Treated | ||
Female | 70s | Surgery | Endometrial cancer | Endometrial cancer | Endometrial adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 80s | Surgery | Renal pelvic cancer | Renal pelvic cancer | Urothelial carcinoma | Primary | Stage2 | Naïve | ||
Male | 60s | Surgery | Rare cancers and sarcomas | Lung Cancer | Small cell carcinoma | Primary | Stage2 | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 30s | Biopsy | Breast cancer | Breast cancer | Invasive ductal carcinoma | Metastasis | Recurrence | Treated | ||
Male | 60s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Female | 50s | Surgery | Ovarian cancer | Ovarian cancer | Clear cell adenocarcinoma | Primary | Stage1 | Naïve | ||
Male | 70s | Surgery | Rare cancers and sarcomas | Lung Cancer | Large cell neuroendocrine carcinoma | Primary | Stage1 | Naïve | ||
Male | 50s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Cecal carcinoma | Adenocarcinoma | Primary | Stage3 | Naïve | KRAS A146T, MSI-high | |
Male | 40s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ALK fusion | |
Female | 60s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | KRAS G13R | |
Male | 70s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage2 | Naïve | KRAS G12S | |
Female | 40s | Surgery | Breast cancer | Breast cancer | Invasive ductal carcinoma | Primary | Stage1 | Naïve | BRCA1, TNBC | |
Male | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | KRAS G12D | |
Female | 60s | Surgery | Colorectal cancer | Transverse colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Surgery | Rare cancers and sarcomas | Malignant pleural mesothelioma | Biphasic type | Primary | Stage1 | Naïve | ||
Male | 60s | Surgery | Lung Cancer | Lung Cancer | Non-small cell carcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Surgery | Gastric cancer | Esophagogastric junction carcinoma | Adenosquamous carcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage3 | Treated | ||
Male | 80s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage3 | Naïve | ||
Male | 80s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage2 | Naïve | ||
Male | 70s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage1 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage4 | Naïve | KRAS G13D | |
Female | 50s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | KRAS G12V | |
Male | 70s | Surgery | Rare cancers and sarcomas | Lung Cancer | Large cell carcinoma | Primary | Stage3 | Naïve | ||
Female | 40s | Surgery | Rare cancers and sarcomas | Malignant peritoneal mesothelioma | Metastasis | Recurrence | Treated | |||
Male | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage2 | Naïve | ||
Male | 50s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ||
Male | 70s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage2 | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | KRAS G13D | |
Male | 70s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage2 | Naïve | ||
Male | 60s | Surgery | Gastric cancer | Gastric cancer | Adenocarcinoma(por to mod) | Primary | Stage3 | Treated | ||
Female | 60s | Surgery | Ovarian cancer | Ovarian cancer | Squamous cell carcinoma | Primary | Stage2 | Naïve | ||
Male | 60s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage4 | Treated | ||
Female | 70s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 70s | Surgery | Colorectal cancer | Cecal carcinoma | Adenocarcinoma | Primary | Stage3 | Naïve | KRAS G12V | |
Female | 10s | Surgery | Colorectal cancer | Transverse colon cancer | Adenocarcinoma | Primary | Stage4 | Treated | ||
Male | 60s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage2 | Naïve | KRAS G12D, KRAS G13D | |
Male | 10s | Biopsy | Rare cancers and sarcomas | Osteosarcoma | Metastasis | Recurrence | Treated | |||
Female | 60s | Surgery | Rare cancers and sarcomas | Uterine carcinosarcoma | Primary | Stage4 | Naïve | |||
Male | 70s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | EGFR ex19 del | |
Female | 40s | Surgery | Rare cancers and sarcomas | Leiomyosarcoma | PEComa like | Metastasis | Recurrence | Treated | ||
Male | 60s | Biopsy | Lung Cancer | Lung Cancer | Non-small cell carcinoma | Primary | Stage2 | Naïve | ||
Female | 80s | Surgery | Colorectal cancer | Descending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | KRAS G12V | |
Male | 10s | Biopsy | Rare cancers and sarcomas | Osteosarcoma | Metastasis | Recurrence | Treated | |||
Female | 50s | Surgery | Colorectal cancer | Rectosigmoid cancer | Adenocarcinoma | Primary | Stage3 | Naïve | KRAS G12V | |
Female | 50s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ALK fusion | |
Male | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Transverse colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Female | 40s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Surgery | Lung Cancer | Lung Cancer | Adenosquamous carcinoma | Primary | Stage3 | Naïve | ||
Female | 30s | Surgery | Rare cancers and sarcomas | Lung Cancer | Combined small cell carcinoma | Primary | Stage4 | Treated | ||
Female | 50s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage3 | Treated | KRAS G12S | |
Female | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage4 | Naïve | NRAS Q61K | |
Male | 60s | Biopsy | Bile duct cancer | Gallbladder cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | MDM2 amp | |
Male | 70s | Surgery | Rare cancers and sarcomas | Lung Cancer | Small cell carcinoma | Primary | Stage1 | Naïve | ||
Female | 10s | Biopsy | Rare cancers and sarcomas | CIC gene rearranged sarcoma | Primary | Not Assessed | Naïve | |||
Male | 70s | Surgery | Rare cancers and sarcomas | Lung Cancer | Pleomorphic carcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | BRAF V600E | |
Male | 70s | Surgery | Colorectal cancer | Rectosigmoid cancer | Adenocarcinoma | Primary | Stage3 | Naïve | KRAS G12D | |
Female | 50s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | EGFR ex19 del | |
Male | 50s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 50s | Surgery | Rare cancers and sarcomas | Thymic cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 30s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | Pan-Wild | |
Male | 70s | Surgery | Lung Cancer | Lung Cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 80s | Surgery | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Primary | Stage1 | Naïve | ||
Female | 60s | Biopsy | Lung Cancer | Lung Cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | KRAS G12A | |
Male | 70s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | KRAS G12V | |
Male | 60s | Biopsy | Lung Cancer | Lung Cancer | Squamous cell carcinoma | Metastasis | Stage4 | Treated | MET skipping | |
Female | 10s | Surgery | Rare cancers and sarcomas | CIC gene rearranged sarcoma | Primary | Not Assessed | Treated | |||
Female | 60s | Biopsy | Lung cancer | Lung cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | EGFR L858R | |
Female | 50s | Biopsy | Lung cancer | Lung cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | EGFR ex20ins | |
Male | 80s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 50s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Surgery | Lung cancer | Lung cancer | Squamous cell carcinoma | Primary | Stage1 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Female | 70s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Surgery | Rare cancers and sarcomas | Dermatofibrosarcoma Protuberans | Primary | Not assessed | Naïve | |||
Female | 70s | Surgery | Rare cancers and sarcomas | Myxofibrosarcoma | Primary | Not assessed | Naïve | |||
Male | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 10s | Biopsy | Rare cancers and sarcomas | Rhabdomyosarcoma | Alveolar | Metastasis | Stage4 | Treated | ||
Female | 70s | Biopsy | Rare cancers and sarcomas | Lung cancer | Small cell carcinoma | Primary | Stage4 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 20s | Biopsy | Rare cancers and sarcomas | Rhabdomyosarcoma | Alveolar | Metastasis | Stage4 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 70s | Surgery | Lung cancer | Lung cancer | Squamous cell carcinoma | Primary | Stage2 | Naïve | ||
Female | 40s | Biopsy | Colorectal cancer | Rectal cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ||
Male | 70s | Biopsy | Bile duct cancer | Intrahepatic bile duct cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ||
Male | 40s | Biopsy | Rare cancers and sarcomas | Adenoid cyctic carcinoma | Metastasis | Recurrence | Treated | |||
Male | 50s | Surgery | Rare cancers and sarcomas | Malignant Pleural Mesothelioma | Epithelial | Primary | Recurrence | Treated | ||
Male | 40s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Male | 80s | Surgery | Lung cancer | Lung cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Surgery | Colorectal cancer | Descending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 50s | Surgery | Rare cancers and sarcomas | Gastrointestinal stromal tumor | Gastric GIST | Primary | Stage4 | Treated | ||
Female | 60s | Surgery | Colorectal cancer | Cecal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 50s | Surgery | Rare cancers and sarcomas | Small intestine cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Male | 80s | Biopsy | Lung cancer | Lung cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ||
Male | 60s | Surgery | Rare cancers and sarcomas | Lung cancer | Large cell neuroendocrine carcinoma | Primary | Stage1 | Naïve | ||
Female | 40s | Surgery | Rare cancers and sarcomas | Epithelioid sarcoma | Classical type | Primary | Not Assessed | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Rectosigmoid cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Male | 70s | Surgery | Lung cancer | Lung cancer | Squamous cell carcinoma | Primary | Stage1 | Naïve | ||
Male | 60s | Biopsy | Lung cancer | Lung cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 60s | Biopsy | Bile duct cancer | Gallbladder cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Female | 40s | Biopsy | Lung cancer | Lung cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 70s | Biopsy | Lung cancer | Lung cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ||
Female | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Descending colon cancer | Adenocarcinoma | Primary | Stage2 | Treated | ||
Female | 40s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 70s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Female | 40s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 50s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Male | 60s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Biopsy | Lung cancer | Lung cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ||
Female | 60s | Surgery | Lung cancer | Lung cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 60s | Surgery | Rare cancers and sarcomas | Uterine carcinosarcoma | Primary | Stage3 | Naïve | |||
Male | 80s | Surgery | Gastric cancer | Gastric cancer | Adenocarcinoma (Type 2) | Primary | Stage3 | Naïve | ||
Female | 80s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 40s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage4 | Treated | ||
Male | 70s | Surgery | Rare cancers and sarcomas | Lung cancer | Small cell carcinoma | Primary | Recurrence | Treated | ||
Female | 80s | Surgery | Colorectal cancer | Rectosigmoid cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Female | 60s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Female | 40s | Surgery | Rare cancers and sarcomas | Small intestine cancer | Adenocarcinoma | Metastasis | Stage4 | Naïve | ||
Female | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage2 | Treated | ||
Female | 50s | Surgery | Lung cancer | Lung cancer | Adenocarcinoma | Primary | Stage1 | Naïve | ||
Female | 50s | Surgery | Colorectal cancer | Rectal cancer | Adenocarcinoma | Primary | Stage3 | Naïve | ||
Male | 70s | Surgery | Colorectal cancer | Ascending colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Male | 50s | Surgery | Colorectal cancer | Transverse colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Male | 50s | Surgery | Rare cancers and sarcomas | Malignant Pleural Mesothelioma | Biphasic | Primary | Stage1 | Treated | ||
Female | 80s | Surgery | Colorectal cancer | Descending colon cancer | Adenocarcinoma | Primary | Stage4 | Naïve | ||
Female | 50s | Surgery | Rare cancers and sarcomas | Lung cancer | Combined small cell carcinoma | Primary | Stage4 | Treated | Ad to SCLC transformation | |
Female | 70s | Surgery | Colorectal cancer | Sigmoid colon cancer | Adenocarcinoma | Metastasis | Recurrence | Treated | ||
Male | 70s | Surgery | Lung cancer | Lung cancer | Adenocarcinoma | Primary | Stage2 | Naïve | ||
Male | 60s | Surgery | Lung cancer | Lung cancer | Adenocarcinoma | Primary | Stage4 | Treated | ||
Male | 50s | Biopsy | Lung cancer | Lung cancer | Adenocarcinoma | Metastasis | Stage4 | Treated | ||
Female | 60s | Surgery | Rare cancers and sarcomas | Lung cancer | Small cell carcinoma | Primary | Stage3 | Naïve |